ҩѧרҵӢÓ¡ªÒ©Ñ§´Ê»ã

2025-10-28

°ëºÏ³É¿¹ÉúËØsemisynthetic antibiotics °ë¿¹Ô­haptene

°ëÊýÖÂËÀ¼ÁÁ¿half lethal dose ; median lethal dose; LD50

ÖÆ¼Áѧtechnology of pharmaceutics ÖÆÒ©»¯Ñ§pharmaceutical chemistry

°²Î¿¼Áplacebo òüºÏ¼Áchelating agent °²È«·¶Î§safety range °²È«ÊÔÑé·¨innocuity test method ¸¨»ùprosthetic group ¸¨ÁÏexcipients

¸¨Ã¸coenzyme ¸±×÷ÓÃside effect

¸½¼Ó¼Áadditive ¸ÉÔï¼Ádesiccant;drying agent

¸ÎÊ×¹ýЧӦfirst pass effect of hepar ¸ÐÊÜÆ÷receptor

¸ßÃôÐÔhyperreactivity

¸öÌå²îÒìÐÔinpidual differences; inpidual variation

¸øÒ©·½°¸»ò¸øÒ©ËÙ¶Èdosage regimen or dose rate

¸øÒ©¼ä¸ôdosing interval ¹¤ÒµÒ©¼Áѧindustrial pharmacy

¹²¼Û¼ücovalent bond ·ÇÈ¥¼«»¯Ðͼ¡ËÉÒ©nondepolarizer

·Ö×ÓÒ©Àíѧmolecular pharmacology

·ÅÉä¶¾Àíѧradiotoxicology ·ÅÉäÒ©¼Áѧradiopharmaceutics

Ö°©ÊµÑécarcinogenic test Ö°©Îïcarcinogen

Ö»ûÊÔÑéteratogenic test Ö»ûÎïteratogen

ÖÂÃôÊÔÑésensitization test ×îСÓÐЧÁ¿minimal effective dose ×îСÖÂËÀ¼ÁÁ¿minimal lethal dose;MLD ÖÂÃô×÷ÓÃsensitization

ÖÂËÀÁ¿fatal dose; lethal dose ÖÆ¼Ápreparation

ÖÎÁƵÈЧ£¨Öµ£©therapeutic equivalence ±ä̬·´Ó¦allergy; allergic reaction

±íÃæ»îÐÔsurface activity ±íÃæÕÅÁ¦surface tension

¶ÌÆÚÖ°©ÊµÑéshort term carcinogenic test

°ëË¥ÆÚhalf-life period; half life time

±À½â¶Èdisintegration ±À½â¼Ádisintegrants µ¥¿Ë¡¿¹Ìåmonoclonal antibody µ¨¼îõ¥Ã¸cholinesterase

µÈÕÅÈÜÒºisotonic solution ±¡Ä¤ÒÂfilm-coating ±¥ºÍÈÜÒºsaturated solution ²»Á¼·´Ó¦adverse reaction ²ë¼Áliniments ôú¼Átincture

°üÒÂÆ¬coated tablet ³¤ÆÚ¶¾ÐÔʵÑélong term toxicity test

³¦¸ÎÑ­»·enterohepatic circulation ³¦ÈÜ¿ØÊÍÆ¬enteric controlled release tablets

³¦ÈÜÒÂenteric coating ´¦·½prescription;recipe

µÎÍè¼Ápill µÝÖÊtransmitter

¶¨ÏòÒ©ÎïÖÆ¼Ádirected pharmaceutical preparations ³¤Ð§ÖƼÁprolonged action preparation Öж¾intoxication; poisoning ¶¾Àíѧtoxicology ¶¾ÐÔ·´Ó¦toxic response; toxic reaction

¶ÔÒòÖÎÁÆetiological treatment ¶ÔÖ¢ÖÎÁÆsymptomatic treatment

¶à¹¦ÄÜømultifunctional enzyme ¶à¼ÁÁ¿¸øÒ©multiple dose administration

¶ù²è·Ó°·catecholamine ¶þÖØ¸ÐȾsuperinfection

¹ýÂËfiltration ¹ýÃô¶¾ËØanaphylatoxin

¹ýÃôÐÔÒ©Îï·´Ó¦anaphylactic drug reaction ¹ýÑõ»¯Îïsuperoxide

º¬Á¿¾ùÔȶÈcontent uniformity ºÏ²¢ÓÃÒ©drug combination

ºÏ³ÉÒ©Îïsynthetic drugs ºÏ¼Ámixture

Ö¬ÖÊÌåliposome Ö±³¦¸øÒ©rectal administration

¼ÁÐÍdosage form ¼ÁÁ¿dosage; dose

»ù±¾Ò©Îïessential drugs ¼±ÐÔ¶¾ÐÔʵÑéacute toxicity test ¼ÁÁ¿»òŨ¶ÈµÄÒÀ´æÐÔdose or concentration dependency

»·¾³Ò©Àíѧenvironmental pharmacology ½ºÌåÈÜÒºÐÍÒ©¼Ámedical colloidal solution

ÉúÎï°ëË¥ÆÚbiological half life ÉúÎï¼îalkaloid

ÉúÎïÀûÓöÈbioavailability ÉúÎïÒ©¼Áѧbiopharmacy

ÉúÎïÖÆÆ·biological product ÉúÒ©crude drugs

ÎÈ̬ѪҩŨ¶Èsteady state plasma concentration

ÎïÀíÒ©¼Áѧphysical pharmaceutics Ò©Îïѧpharmacology; materia medica

ÎüÈë·¨inhalation ÎüÊÕËÙÂʳ£Êýabsorption rate constant

ʱ³½Ò©Àíѧchronopharmacology ʱ¼äÖÎÁÆchronotherapy

ʱ¼ä¸ÐÊÜÐÔchronosusceptability ʱЧ¹ØÏµtime-effect relationship ½ÀÓÃÆ¬chewable tablets ½Í½âglycolysis

Þ׿¹×÷ÓÃantagonism ½â¶¾×÷ÓÃdetoxication

½éÖÊmediator; transmitter; medium ¾«ÉñÒÀÀµÐÔpsychic dependence

¾çÒ©powerful drug ¾ø¶ÔÖÂËÀ¼ÁÁ¿absolute lethal dose; LD100

¹ãÆ×¿¹ÉúËØbroad-spectrum antibiotic

¿¹¶¾ËØantitoxin ¿¹¾úÆ×antibacterial spectrum

¿¹Ò©ÐÔresistance to drugs ¿ØÊÍÖÆ¼Ácontrolled release preparation

¿ÚÇ»ÄÚ¸øÒ©oral administration ¿ìËÙÄÍÊÜtachyphylaxis

À©É¢diffusion À©É¢ÏµÊýcoefficient of diffusion ÀÛ»ýÄòÅÅйÇúÏßcumulative urinary excretion curves

ÀÛ¼ÓЧӦadditive effect Àà¶¾ËØanatoxin;toxoid

Àà¹Ì´¼Í£Ò©×ÛºÏÕ÷steroid withdrawal syndrome

Á¿×ÓÒ©Àíѧquantum pharmacology µ÷¼Áѧdispensing pharmacy ÁÙ´²Ò©Àíѧclinical pharmacology ÁÙ´²Ò©Ñ§chlinical pharmacy

ÄÍÊÜÐÔtolerance ÄÍÒ©ÐÔdrug tolerance

ÄÚ¶¾ËØendotoxin Ƭ¼ÁÓ²¶Ètablet hardness

ÄÚ¶¾ËØö×ÊÔ¼Á²â¶¨·¨Limulus Amebocyte Lysate assay for endotoxin

ÄÚÏûÐýÌåmesomer Ũ¶Èconcentration

Ƥ·ô¡¢Õ³Ä¤±íÃæ¸øÒ©skin and mucocutaneous administration

ÆøÄý½ºaerogel ÆøÈܽºaerosol

ÆøÌå·ÖÎögas analysis ÆøÎí¼Áaerosol

ǰÌåÒ©Îïprodrug ÇÊÄÚ×¢Éäintrathecal injection

ÏÞÖÆÐÔ¾çÒ©restrictive holagogue Ïà¶Ô¸øÒ©¼ä¸ôrelative dosage interval

Ïà¼Ó×÷ÓÃadditive effect; addition Ïò°Ð¸øÒ©targetable drug delivery ҩЧ¶¯Á¦Ñ§pharmacodynamics Ò©Ô´ÐÔ¼²²¡drug-induced diseases

ÒÒõ£µ¨¼îÒÒõ£µ¨¼îacetylcholine ÒÒõ£µ¨¼îõ¥Ã¸acetylcholinesterase

ÒÖ¾ú»îÐÔbacteriostatic activity ÒÖ¾ú×÷ÓÃbactriostasis

Ò칹øisomerase

Ïû³ýËÙÂʳ£Êýelimination rate constant Ч¼Ûpotency

Ч¼Ûµ¥Î»potency unit Ч¼ÛÇ¿¶Èpotency

ЧӦeffect ЧӦÆ÷effector

ЧӦÎïeffector Эͬ×÷ÓÃsynergism

ÐË·ÜÐÔexcitability Ñ¡ÔñÐÔselectivity

Ðü¸¡Òºsuspension

Ѫ¹ÜÄÚ¸øÒ©intravascular administration Ѫ¹ÜÍâ¸øÒ©extravascular administration

Ѫ½¬plasma Ѫ½¬´úÓÃÒºplasma substitute Ѫ½¬µ°°×½áºÏÂÊplasma protein binding ratio

ѪÄÔÆÁÕÏblood-cerebral barrier ѪҩŨ¶Èblood concentration

ѪÇåserum ѪҺÄý¹Ìblood coagulation ѪÈÝÁ¿À©³ä¼Áblood volume expander ÑªÒºÖÆÆ·blood products

ÑǼ±ÐÔÖж¾subacute intoxication;subacute poisoning

ÑÇÏõËáÑÎÖж¾nitrite poisoning ÑÛÓÃĤ¼Áocular inserts

Ò©¡ªÊ±°ë¶ÔÊýÇúÏßsemi-logarithmic curve of drug-time

Ò©¡ªÊ±ÇúÏßdrug-time curve Ò©·åŨ¶Èpeak concentration of drug

Ò©·åʱ¼äpeak time of drug Ò©¼ÁµÈЧÐÔpharmaceutical equivalence

Ò©¼Áѧpharmaceutics Ò©Àíѧpharmacology

Ò©ÃôÊÔÑédrug sensitive test

Ò©Îï´úлdrug metabolism Ò©Îï´úлødrug metablic enzyme

Ò©ÎïµÄÌåÄÚ¹ý³Ìintracorporal process of drugs

Ò©ÎﶯÁ¦Ñ§Ä£ÐÍpharmacokinetics model

Ò©Îï·´Ó¦drug reaction Ò©Îï·Ö²¼drug distribution

Ò©ÎïÅÅйdrug excretion Ò©ÎïÎüÊÕdrug absorption

Ò©ÎïÏ໥×÷ÓÃdrug interaction Ò©ÎïÏû³ýdrug elimination

Ò©ÎïÐî»ýdrug accumulation ȫøÓ븨»ùholonzyme and prosthetic group

È˹¤ºÏ³É¿¹Ô­artificial antigen È˹¤ÃâÒßartificial immunization ÈËÖÖÒ©Àíѧethnopharmacology ÂñÖ²¼Áimplants

ÂýͨµÀslow pathway Ãô¸ÐÐÔsensitivity

ÂýÐÔ¶¾ÐÔʵÑéchronic toxicity test; long term toxicity test

øenzyme øԭproenzyme

ÃâÒßÒÖÖÆ¼Áimmunosuppressant;immuno inhibitor

ÃâÒßÔ­ÐÔimmunogenicity ÃâÒßÔöÇ¿¼Áimmunoenhancement ¿¹Ìåantibody ¿¹ÑªÇåantiserum

¿¹Ô­antigen Èܽâdissolution; dissolving

Èܾúølysozyme ÈÜѪhemolysis

ÈÜÖÊsolute ÈýôÈËáÑ­»·tricarboxylic acid cycle ɱ¾ú»îÐÔbactericidal activity ɱ¾ú×÷ÓÃbactericidal effect

ÉíÌåÒÀÀµÐÔphysical dependence Éñ¾­¶¾ËØneurotoxin

ÉöÉÏÏÙËØÄÜÉñ¾­adrenergic nerve ÉöÉÏÏÙËØÄÜÊÜÌåadrenergic receptor ÉøÍ¸Ñ¹osmotic pressure ÈܼÁsolvent; dissolvent

ÊÕÁ²Ò©astringent ÊÖÐÔÒ©Îïchiral drug

Ê×¹ýЧӦfirst-pass effect ÊÜÌåreceptor

Ë®½â£¨×÷Óã©hydrolysis ÌÇÒìÉú×÷ÓÃgluconeogenesis

ҩѧרҵӢÓ¡ªÒ©Ñ§´Ê»ã.doc ½«±¾ÎĵÄWordÎĵµÏÂÔØµ½µçÄÔ ÏÂÔØÊ§°Ü»òÕßÎĵµ²»ÍêÕû£¬ÇëÁªÏµ¿Í·þÈËÔ±½â¾ö£¡

ÏÂһƪ£º¿Õ¼ä¼¸ºÎÌå֪ʶµã¹éÄÉ

Ïà¹ØÔĶÁ
±¾ÀàÅÅÐÐ
¡Á ÓοͿì½ÝÏÂÔØÍ¨µÀ£¨ÏÂÔØºó¿ÉÒÔ×ÔÓɸ´ÖƺÍÅŰ棩

ÏÂÔØ±¾ÎĵµÐèÒªÖ§¸¶ 7 Ôª

Ö§¸¶·½Ê½£º

¿ªÍ¨VIP°üÔ»áÔ± ÌØ¼Û£º29Ôª/ÔÂ

×¢£ºÏÂÔØÎĵµÓпÉÄÜ¡°Ö»ÓÐĿ¼»òÕßÄÚÈݲ»È«¡±µÈÇé¿ö£¬ÇëÏÂÔØÖ®Ç°×¢Òâ±æ±ð£¬Èç¹ûÄúÒѸ¶·ÑÇÒÎÞ·¨ÏÂÔØ»òÄÚÈÝÓÐÎÊÌ⣬ÇëÁªÏµÎÒÃÇЭÖúÄã´¦Àí¡£
΢ÐÅ£ºxuecool-com QQ£º370150219